D.A. Davidson & Co.
- SEC CIK
- 0001080107
- Latest filing
- Jul 24, 2026
VRNA holding history
Verona Pharma plc in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRNA overviewAll 13F holders of VRNAFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −33,400−100.0% | Sold out | Holders |
| Q4 2023 | 33,400 | $664.0K | <0.1% | +900+2.8% | Added | Holders |
| Q3 2023 | 32,500 | $529.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 32,500 | $687.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 32,500 | $652.6K | <0.1% | −1,500−4.4% | Reduced | Holders |
| Q4 2022 | 34,000 | $888.4K | <0.1% | −6,000−15.0% | Reduced | Holders |
| Q3 2022 | 40,000 | $409.0K | <0.1% | −4,500−10.1% | Reduced | Holders |
| Q2 2022 | 44,500 | $186.0K | <0.1% | −3,500−7.3% | Reduced | Holders |
| Q1 2022 | 48,000 | $240.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 48,000 | $323.0K | <0.1% | +8,000+20.0% | Added | Holders |
| Q3 2021 | 40,000 | $219.0K | <0.1% | −1,900−4.5% | Reduced | Holders |
| Q2 2021 | 41,900 | $274.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 41,900 | $350.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.